Page 6 - ஆக்ஸ்ஃபர்ட் பல்கலைக்கழகம் நுஃபையீல்ட் துறை ஆஃப் பாப்யுலேஶந் ஆரோக்கியம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Arthritis Drug Tocilizumab Reduces Severe Covid Mortality: Study By Patrick GALEY 02/11/21 AT 10:00 AM The arthritis drug tocilizumab reduces the risk of critically ill patients dying of Covid-19, according to results of a study on Thursday which experts welcomed as an exciting development. The Britain-based RECOVERY research programme investigating Covid-19 treatments said their findings could have a significant effect on hospital survival rates during the pandemic. The study included more than 2,000 patients who received the drug intravenously compared with nearly 3,000 who were given normal care alone, such as oxygen support and ventilation. More than 80 percent of all the patients were also receiving steroid treatments such as dexamethasone, which had been shown in earlier trials to lower the risk of death.

United kingdomCity ofAnthony gordonMartin landrayAthimalaipet ramananResearch professor at imperial college londonUniversity of bristolOxford university nuffield department of population healthOxford universityNuffield departmentCritical careImperial college londonPaediatric rheumatologyCo vidஒன்றுபட்டது கிஂக்டம்நகரம் ஆஃப்